The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Resistance in nonfermenting gram-negative bacteria: Multidrug resistance to the maximum
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
System, A. R. F. T. N. (2004) · American Journal of Infection Control · doi:10.1016/j.ajic.2004.10.001 · Cited by 2,342
Inadequate Antimicrobial Treatment of Infections
Kollef, M. H., Sherman, G., Ward, S., & Fraser, V. J. (1999) · Chest · doi:10.1378/chest.115.2.462 · Cited by 1,805
Ibrahim, E. H., Sherman, G., Ward, S., Fraser, V. J., & Kollef, M. H. (2000) · Chest · doi:10.1378/chest.118.1.146 · Cited by 1,779
Overview of Nosocomial Infections Caused by Gram-Negative Bacilli
Weinstein, R. A., Gaynes, R., Edwards, J. R., & System, N. N. I. S. (2005) · Clinical Infectious Diseases · doi:10.1086/432803 · Cited by 1,404
Trends in antimicrobial drug development: Implications for the future
Spellberg, B., Powers, J. H., Brass, E. P., Miller, L. G., & Edwards, J. E. (2004) · Clinical Infectious Diseases · doi:10.1086/420937 · Cited by 867
Kang, C.-I., Kim, S.-H., Park, W. B., Lee, K.-D., Kim, H.-B., Kim, E.-C., Oh, M.-D., & Choe, K.-W. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.760-766.2005 · Cited by 692
Neuhauser, M. M., Weinstein, R. A., Rydman, R., Danziger, L. H., Karam, G., & Quinn, J. P. (2003) · JAMA · doi:10.1001/jama.289.7.885 · Cited by 678
The Impact of Antimicrobial Resistance on Health and Economic Outcomes
Eliopoulos, G. M., Cosgrove, S. E., & Carmeli, Y. (2003) · Clinical Infectious Diseases · doi:10.1086/375081 · Cited by 637
Transferable imipenem resistance in Pseudomonas aeruginosa
Watanabe, M., Iyobe, S., Inoue, M., & Mitsuhashi, S. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.1.147 · Cited by 619
Micek, S. T., Lloyd, A. E., Ritchie, D. J., Reichley, R. M., Fraser, V. J., & Kollef, M. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1306-1311.2005 · Cited by 526
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatment
Hancock, R. E. W., & Speert, D. P. (2000) · Drug Resistance Updates · doi:10.1054/drup.2000.0152 · Cited by 515
Aminoglycoside Resistance in Pseudomonas aeruginosa
Poole, K. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.479-487.2005 · Cited by 470
Karlowsky, J. A., Draghi, D. C., Jones, M. E., Thornsberry, C., Friedland, I. R., & Sahm, D. F. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.5.1681-1688.2003 · Cited by 351
Detection of Pseudomonas aeruginosa Producing Metallo-β-Lactamases in a Large Centralized Laboratory
Pitout, J. D. D., Gregson, D. B., Poirel, L., McClure, J.-A., Le, P., & Church, D. L. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.7.3129-3135.2005 · Cited by 331
ANTIMICROBIAL RESISTANCE IN INTENSIVE CARE UNITS
Fridkin, S. K., & Gaynes, R. P. (1999) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(05)70143-x · Cited by 325
Infection Control in Cystic Fibrosis
Saiman, L., & Siegel, J. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.1.57-71.2004 · Cited by 324
Antimicrobial Resistance Determinants and Future Control
Harbarth, S., & Samore, M. H. (2005) · Emerging Infectious Diseases · doi:10.3201/eid1106.050167 · Cited by 315
Economic Impact of Antimicrobial Resistance
McGowan, J. E. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0702.010228 · Cited by 271
Self-citationBurkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis
Jones, A. M. (2004) · Thorax · doi:10.1136/thx.2003.017210 · Cited by 250
Weldhagen, G. F., Poirel, L., & Nordmann, P. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2385-2392.2003 · Cited by 231
Multidrug-Resistant Acinetobacter Infections: An Emerging Challenge to Clinicians
Jain, R., & Danziger, L. H. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1d592 · Cited by 219
Clinical Problems Posed by Multiresistant Nonfermenting Gram‐Negative Pathogens
Quinn, J. P. (1998) · Clinical Infectious Diseases · doi:10.1086/514912 · Cited by 213
Michalopoulos, A., Kasiakou, S. K., Mastora, Z., Rellos, K., Kapaskelis, A. M., & Falagas, M. E. (2004) · Critical Care · doi:10.1186/cc3020 · Cited by 209
Hyle, E. P., Lipworth, A. D., Zaoutis, T. E., Nachamkin, I., Bilker, W. B., & Lautenbach, E. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.12.1375 · Cited by 194
Streit, J. M., Jones, R. N., Sader, H. S., & Fritsche, T. R. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2003.12.019 · Cited by 191
Ouderkirk, J. P., Nord, J. A., Turett, G. S., & Kislak, J. W. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2659-2662.2003 · Cited by 188
Paramythiotou, E., Lucet, J., Timsit, J., Vanjak, D., Paugam‐Burtz, C., Trouillet, J., Belloc, S., Kassis, N., Karabinis, A., & Andremont, A. (2004) · Clinical Infectious Diseases · doi:10.1086/381550 · Cited by 177
Trouillet, J. L., Vuagnat, A., Combes, A., Kassis, N., Chastre, J., & Gibert, C. (2002) · Clinical Infectious Diseases · doi:10.1086/339488 · Cited by 176
Toleman, M. A., Rolston, K. V., Jones, R. N., & Walsh, T. R. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.329-332.2004 · Cited by 143
Mutations in GyrA, ParC, MexR and NfxB in clinical isolates of Pseudomonas aeruginosa
Higgins, P. G. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(03)00009-8 · Cited by 138
Kriengkauykiat, J., Porter, E. M., Lomovskaya, O., & Wong‐Beringer, A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.565-570.2005 · Cited by 137
Hoban, D. J., Biedenbach, D. J., Mutnick, A. H., & Jones, R. N. (2003) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(02)00540-0 · Cited by 136
Andrade, S. S. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg270 · Cited by 117
Hsu, D. I., Okamoto, M. P., Murthy, R. K., & Wong‐Beringer, A. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki026 · Cited by 87
Thomas, I. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.4.553 · Cited by 72
Zhang, L. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.4.549 · Cited by 70
Emerging epidemic of metallo-β-lactamase–mediated resistances
Jones, R. N., Biedenbach, D. J., Sader, H. S., Fritsche, T. R., Toleman, M. A., & Walsh, T. R. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2004.07.003 · Cited by 53
Emergence of IMP-4 metallo-β-lactamase in a clinical isolate from Australia
Peleg, A. Y., Franklin, C., Bell, J. M., & Spelman, D. W. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh398 · Cited by 48
Leroy, O., d’Escrivan, T., Devos, P., Dubreuil, L. J., Kipnis, É., & Georges, H. (2005) · Infection · doi:10.1007/s15010-005-4021-8 · Cited by 41
Cited by
Magiorakos, A.-P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., Harbarth, S., Hindler, J. F., Kahlmeter, G., Olsson-Liljequist, B., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03570.x · Cited by 14,449
Spellberg, B., Guidos, R., Gilbert, D., Bradley, J., Boucher, H. W., Scheld, W. M., Bartlett, J. G., Edwards, J., & the Infectious Diseases Society of America (2008) · Clinical Infectious Diseases · doi:10.1086/524891 · Cited by 1,642
The antibiotic resistome: the nexus of chemical and genetic diversity
Wright, G. D. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1614 · Cited by 1,365
Water pollution in Pakistan and its impact on public health — A review
Azizullah, A., Khattak, M. N. K., Richter, P., & Häder, D.-P. (2011) · Environment International · doi:10.1016/j.envint.2010.10.007 · Cited by 890
Pseudomonas aeruginosa – a phenomenon of bacterial resistance
Strateva, T., & Yordanov, D. (2009) · Journal of Medical Microbiology · doi:10.1099/jmm.0.009142-0 · Cited by 803
Metadata
- Authors
- McGowan, J. E.
- Venue
- American Journal of Infection Control
- Publisher
- Elsevier BV
- Published
- 2006-06
- Volume
- 34
- Issue
- 5
- Pages
- S29-S37
- ISSN
- 0196-6553 (ISSN-L)
- OpenAlex
- W2076633952
- Cited by
- 312
- References
- 39
- FWCI
- 11.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.